chr7-122303915-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_001024613.4(FEZF1):āc.523G>Cā(p.Gly175Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,612,876 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001024613.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEZF1 | NM_001024613.4 | c.523G>C | p.Gly175Arg | missense_variant | 1/4 | ENST00000442488.7 | NP_001019784.2 | |
FEZF1-AS1 | NR_036484.1 | n.258C>G | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF1 | ENST00000442488.7 | c.523G>C | p.Gly175Arg | missense_variant | 1/4 | 1 | NM_001024613.4 | ENSP00000411145 | P2 | |
FEZF1 | ENST00000427185.2 | c.430-57G>C | intron_variant | 1 | ENSP00000392727 | A2 | ||||
FEZF1-AS1 | ENST00000428449.5 | n.258C>G | non_coding_transcript_exon_variant | 1/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000625 AC: 154AN: 246242Hom.: 0 AF XY: 0.000449 AC XY: 60AN XY: 133584
GnomAD4 exome AF: 0.000152 AC: 222AN: 1460522Hom.: 1 Cov.: 33 AF XY: 0.000131 AC XY: 95AN XY: 726484
GnomAD4 genome AF: 0.000374 AC: 57AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.000362 AC XY: 27AN XY: 74504
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
FEZF1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 19, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at